Network pharmacology and experimental study of Angelica sinensis and Astragalus membranaceus capsules in treating heart failure
This study preliminarily reveals that AAC can treat HF through multiple components and multiple targets by using network pharmacology, molecular docking, and experimental validation.
Authors
- Liu Ai (ORCID: https://orcid.org/0000-0001-8222-2157)
- Xiaodong Zhi
- Xinfang Lv (ORCID: https://orcid.org/0000-0002-9885-907X)
- Xue Wu (ORCID: https://orcid.org/0000-0001-5736-6044)
- Kai Liu (ORCID: https://orcid.org/0000-0001-5336-7939)
- Xiangting Zeng (ORCID: https://orcid.org/0000-0003-4967-9432)
- Yingdong Li (ORCID: https://orcid.org/0000-0001-7184-7290)
- Bing Jiang (ORCID: https://orcid.org/0000-0001-6594-4019)
- Xinke Zhao (ORCID: https://orcid.org/0000-0002-3460-7279)
- Hugang Jiang
Institutions
- Gansu University of Traditional Chinese Medicine (CN)
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e38851
- Citations
- 1
- Primary Topic
- Traditional Chinese Medicine Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.72